Short Pulse Anti Retroviral Therapy at HIV Seroconversion (SPARTAC)

SPARTAC is the largest randomised control trial ever undertaken in recent HIV infection. The study ran between 2003 and 2011 across eight countries. The aim of SPARTAC was to examine whether treating people recently infected with HIV with anti-HIV drugs for a short period of time could slow down the damage caused by HIV to the immune system and consequently delay the need to start long-term treatment.